Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
67.11B | 67.73B | 56.79B | 49.98B | 44.06B | 50.77B | Gross Profit |
16.84B | 16.35B | 13.40B | 11.87B | 11.07B | 12.76B | EBIT |
4.37B | 4.55B | 3.65B | 2.68B | 2.63B | 3.42B | EBITDA |
6.13B | 7.30B | 5.50B | 4.69B | 5.18B | 6.11B | Net Income Common Stockholders |
3.22B | 3.60B | 2.48B | 1.52B | 2.38B | 2.51B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
20.35B | 18.94B | 18.02B | 14.77B | 14.25B | 12.06B | Total Assets |
70.29B | 69.39B | 60.16B | 54.30B | 53.24B | 51.25B | Total Debt |
5.34B | 5.75B | 5.53B | 5.15B | 4.94B | 5.04B | Net Debt |
-15.00B | -13.19B | -12.47B | -9.60B | -9.31B | -7.03B | Total Liabilities |
23.51B | 25.07B | 21.12B | 18.77B | 18.56B | 18.46B | Stockholders Equity |
43.94B | 41.56B | 36.65B | 33.39B | 31.97B | 30.23B |
Cash Flow | Free Cash Flow | ||||
0.00 | 3.95B | 3.06B | 988.00M | 3.35B | 1.53B | Operating Cash Flow |
0.00 | 5.33B | 4.17B | 2.10B | 4.32B | 3.76B | Investing Cash Flow |
0.00 | -3.90B | -2.51B | -1.46B | -1.81B | -1.87B | Financing Cash Flow |
0.00 | -1.70B | -482.00M | -1.69B | -574.00M | -1.43B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
85 Outperform | ¥20.75B | 7.25 | 3.07% | 3.37% | -21.94% | ||
73 Outperform | ¥19.17B | 6.69 | 4.93% | 7.61% | -31.96% | ||
72 Outperform | ¥27.70B | 8.25 | 5.38% | -0.98% | 26.20% | ||
71 Outperform | ¥15.33B | 7.24 | 7.46% | -3.83% | 4.11% | ||
66 Neutral | $4.47B | 12.21 | 5.40% | 3.65% | 4.14% | -12.00% | |
63 Neutral | ¥25.61B | 17.53 | 3.34% | 5.69% | 202.27% | ||
62 Neutral | ¥7.01B | 22.32 | 3.13% | -1.16% | -8.99% |